首頁 > 市場調查報告書 > 消費品

健康美容化妝品

市場調查報告書

商品編碼

1822386

二氧化碳療法市場預測至 2032 年：按產品類型、療法類型、氣體類型、設備類型、應用、最終用戶和地區進行的全球分析

Carboxy Therapy Market Forecasts to 2032 - Global Analysis By Product Type (Tabletop Devices, Portable Devices, and Other Product Types), Treatment Type, Gas Type, Device Type, Application, End User, and By Geography

出版日期: 2025年09月07日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，全球二氧化碳療法市場預計在 2025 年達到 5,006 萬美元，到 2032 年將達到 1.245 億美元，預測期內複合年成長率為 13.9%。

二氧化碳療法是一種非手術美容療法，透過皮下注射定量的二氧化碳氣體來實現。該療法透過促進血液循環、增加氧氣輸送和刺激膠原蛋白生成來發揮作用。它通常用於減少橘皮組織、疤痕、妊娠紋和頑固脂肪，同時改善皮膚緊緻度和紋理。透過自然的組織修復和再生，二氧化碳療法為改善皮膚和塑造體形提供了一個有效、微創的方案。

整容手術正在興起，國際美容整形整形外科學會 (ISAPS) 最近發布的統計數據顯示，2021 年整容手術總體增加了 19.3%。

非侵入性美容手術的需求不斷增加

非侵入性美容療法日益偏好，這極大地推動了二氧化碳療法市場的發展。消費者越來越傾向於選擇那些效果顯著、恢復期短且風險低的療法。設備精度和氣體輸送系統的進步正在提高治療效果和患者舒適度。社群媒體和美妝達人的崛起，正在推動人們對活膚和減少脂肪團治療的認知和需求。診所正在將二氧化碳療法融入其更廣泛的抗衰老和塑身產品組合中，並藉助數位影像和個人化治療方案。隨著美容醫學轉向預防和維護型護理，像二氧化碳療法這樣的非侵入性治療方法正成為主流。

不同的監管政策和安全問題

核准流程差異很大，一些國家實施了嚴格的臨床檢驗和設備認證標準。圍繞氣體純度、劑量控制和通訊協定的安全問題正在推動監管力度的加強。製造商必須應對複雜的合規環境，包括 CE 標誌、FDA 批准和 ISO 標準。智慧感測器和自動流量穩壓器的整合有助於彌補安全漏洞，但也增加了監管複雜性。規模較小的公司經常面臨延誤和成本負擔，這限制了創新，並減緩了產品在關鍵市場的推出。

美容診所的興起

提供先進皮膚護理的精品醫療水療中心和皮膚科連鎖店正在城區和二線城市蓬勃發展。診所正在投資緊湊型多功能設備，以支持二氧化碳療法以及微針和射頻等其他療法。在新興市場，專利權模式和承包解決方案的採用正在加速設備的普及。數位行銷和線上預約平台正在擴大患者就診管道，並增加治療量。在競爭日益激烈的背景下，診所正透過技術升級、個人化護理和配套服務來脫穎而出。

可能造成負面宣傳和消費者不信任

負面體驗在社群媒體上被放大，會削弱消費者的信任，並減少新用戶的使用。醫療服務提供者缺乏標準化的培訓和認證，導致流程差異化。監管機構擴大要求提供者認證和設備可追溯性，以減少醫療失誤。企業正在透過進行病患教育宣傳活動和透明的安全資料來恢復信任。然而，如果沒有強力的品質保證和治療後支持，市場仍然容易受到質疑和抵制。

COVID-19的影響

疫情擾亂了美容醫療服務的提供，封鎖措施導致選擇性治療暫停，門診就診量減少。供應鏈中斷影響了設備的可用性和維護週期，減緩了新設備的安裝。然而，這場危機加速了數位化，診所開始採用虛擬諮詢和遠端皮膚評估。疫情過後，隨著消費者更加重視自我護理和改善外貌，需求開始復甦。醫療服務的分散化和向家用設備的轉變正在重塑美容治療的交付模式。

預計桌上型設備市場在預測期內將佔據最大佔有率

桌上型設備憑藉其多功能性和臨床級性能，預計將在預測期內佔據最大的市場佔有率。這些系統提供精確的氣流控制、可客製化的治療通訊協定，並相容於多種探頭。診所青睞桌上型設備，因為它們耐用、符合人體工學設計，並且能夠處理大量患者。觸控螢幕介面和即時監控的整合提高了易用性和治療精度。製造商正專注於模組化升級和軟體主導的增強功能，以延長設備的生命週期。隨著對專業級設備的需求不斷成長，桌上型系統仍然是美容基礎設施的支柱。

預測期內，Medspa 細分市場將以最高複合年成長率成長

在健康與美容護理混合模式的推動下，醫療水療中心 (Medspa) 預計將在預測期內實現最高成長率。這些機構正迅速採用二氧化碳療法作為整體活膚和抗衰老療法的一部分。非侵入性治療和最短的恢復時間與醫療水療中心的客戶群相契合。人工智慧皮膚分析與個人化治療方案的結合正在推動該療法的普及。醫療水療中心正在利用影響力行銷和訂閱式服務模式來留住客戶並擴大業務規模。隨著消費者需求轉向體驗式和結果導向護理，醫療水療中心正逐漸成為重要的成長中心。

比最大的地區

在預測期內，受可支配收入成長和美容意識增強的推動，亞太地區預計將佔據最大的市場佔有率。韓國、中國和印度等國家正經歷美容診所和皮膚科中心的快速擴張。政府推動醫療旅遊和設備在地化的舉措正在刺激市場滲透。區域參與者正在與全球原始設備製造商合作，推出經濟高效且符合當地文化的解決方案。美白、抗衰老和減少疤痕療法的流行推動了二氧化碳療法的廣泛應用。技術進步和積極的行銷策略正在鞏固亞太地區在美容創新領域的領導地位。

複合年成長率最高的地區：

預計北美將在預測期內呈現最高的複合年成長率，這得益於強勁的研發實力和早期技術應用。美國和加拿大擴大採用整合分析和雲端基礎治療追蹤功能的智慧美容設備。監管機構正在簡化創新非侵入性治療方法的核准途徑，加速其商業化進程。診所正在投資培訓、認證和配套服務，以改善患者的治療效果。注重健康的消費者的崛起和對個人化護膚的需求正在推動治療數量的成長。憑藉著日趨成熟的數位平台和影響力生態系統，北美將持續引領美容市場的發展。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

公司簡介
- 對最多三家其他市場公司進行全面分析
- 主要企業的SWOT分析（最多3家公司）
區域細分
- 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
競爭基準化分析
- 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 義大利
- 法國
- 西班牙
- 其他歐洲國家
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 紐西蘭
- 韓國
- 其他亞太地區
南美洲
- 阿根廷
- 巴西
- 智利
- 南美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 卡達
- 南非
- 其他中東和非洲地區

第12章重大進展

協議、夥伴關係、合作和合資企業
收購與合併
新產品發布
業務擴展
其他關鍵策略

第13章：企業概況

Fosun Pharmaceutical Co., Ltd.
MBE Medical Division
Merz Pharma GmbH & Co. KGaA
Medipark Co., Ltd.
Allergan plc
Italcarbo Srl
Alvi Prague
Mezopharma
JONTE
Kastner-Praxisbedarf
Anti-Aging Medical Systems
Carbossiterapia Italiana
DTA Medical
Beijing Jontelaser Technologies Co., Ltd.
Cosmo Pro Ltd

簡介目錄圖表

Product Code: SMRC31140

According to Stratistics MRC, the Global Carboxy Therapy Market is accounted for $50.06 million in 2025 and is expected to reach $124.50 million by 2032 growing at a CAGR of 13.9% during the forecast period. Carboxy Therapy is a non-surgical aesthetic procedure where controlled amounts of carbon dioxide gas are injected under the skin. The treatment works by boosting blood circulation, increasing oxygen delivery, and stimulating collagen formation. Commonly applied to minimize cellulite, scars, stretch marks, and stubborn fat, it enhances skin firmness and texture. Through natural tissue repair and rejuvenation, Carboxy Therapy provides an effective, minimally invasive option for skin improvement and body contouring.

According to recent statistics published by the International Society of Aesthetic Plastic Surgery (ISAPS), aesthetic and cosmetic procedures have seen a surge with an overall increase of 19.3% of plastic surgeries performed in 2021.

Market Dynamics:

Driver:

Increasing demand for non-invasive aesthetic procedures

The growing preference for non-invasive cosmetic treatments is significantly propelling the carboxy therapy market. Consumers are increasingly opting for procedures that offer visible results with minimal downtime and reduced risk. Advancements in device precision and gas delivery systems are enhancing treatment efficacy and patient comfort. The rise of social media and beauty influencers is amplifying awareness and demand for skin rejuvenation and cellulite reduction therapies. Clinics are integrating carboxy therapy into broader anti-aging and body contouring portfolios, supported by digital imaging and personalized treatment planning. As aesthetic medicine shifts toward preventive and maintenance-based care, non-invasive modalities like carboxy therapy are gaining mainstream traction.

Restraint:

Varying regulatory policies and safety concerns

Approval processes differ widely, with some countries enforcing stringent clinical validation and device certification standards. Safety concerns around gas purity, dosage control, and procedural protocols are prompting tighter oversight. Manufacturers must navigate complex compliance landscapes, including CE marking, FDA clearance, and ISO standards. The integration of smart sensors and automated flow regulators is helping address safety gaps but adds to regulatory complexity. Smaller players often face delays and cost burdens, limiting innovation and slowing product rollout in key markets.

Opportunity:

Increasing number of aesthetic clinics

Urban centers and tier-2 cities are witnessing a surge in boutique medspas and dermatology chains offering advanced skin treatments. Clinics are investing in compact, multi-functional devices that support carboxy therapy alongside other modalities like microneedling and RF. Emerging markets are embracing franchised models and turnkey solutions, accelerating device adoption. Digital marketing and online booking platforms are expanding patient access and driving procedural volumes. As competition intensifies, clinics are differentiating through technology upgrades, personalized care, and bundled service offerings.

Threat:

Potential for negative publicity and consumer distrust

Social media amplification of negative experiences may erode consumer confidence and deter new users. Lack of standardized training and certification across providers contributes to procedural variability. Regulatory bodies are increasingly mandating practitioner accreditation and device traceability to mitigate malpractice. Companies are responding with patient education campaigns and transparent safety data to rebuild trust. However, without robust quality assurance and post-treatment support, the market remains vulnerable to skepticism and backlash.

Covid-19 Impact

The pandemic disrupted aesthetic service delivery, with lockdowns halting elective procedures and reducing clinic footfall. Supply chain interruptions affected device availability and maintenance cycles, delaying new installations. However, the crisis accelerated digital engagement, with clinics adopting virtual consultations and remote skin assessments. Demand rebounded post-pandemic as consumers prioritized self-care and appearance enhancement. The shift toward decentralized care and home-use devices is reshaping the delivery model for aesthetic treatments.

The tabletop devices segment is expected to be the largest during the forecast period

The tabletop devices segment is expected to account for the largest market share during the forecast period, due to its versatility and clinical-grade performance. These systems offer precise gas flow control, customizable treatment protocols, and compatibility with multiple applicators. Clinics prefer tabletop units for their durability, ergonomic design, and ability to handle high patient volumes. Integration of touchscreen interfaces and real-time monitoring is enhancing usability and treatment accuracy. Manufacturers are focusing on modular upgrades and software-driven enhancements to extend device lifecycle. As demand for professional-grade equipment rises, tabletop systems remain the backbone of aesthetic infrastructure.

The medspas segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the medspas segment is predicted to witness the highest growth rate, driven by their hybrid model of wellness and cosmetic care. These facilities are rapidly adopting carboxy therapy as part of holistic skin rejuvenation and anti-aging packages. The appeal of non-invasive treatments with minimal recovery time aligns well with medspa clientele. Integration of AI-based skin analysis and personalized treatment plans is boosting procedural uptake. Medspas are leveraging influencer marketing and subscription-based service models to retain customers and scale operations. As consumer demand shifts toward experiential and results-driven care, medspas are emerging as key growth hubs.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share supported by rising disposable incomes and beauty consciousness. Countries like South Korea, China, and India are witnessing rapid expansion of aesthetic clinics and dermatology centers. Government initiatives promoting medical tourism and device localization are fueling market penetration. Regional players are collaborating with global OEMs to introduce cost-effective, culturally tailored solutions. The popularity of skin whitening, anti-aging, and scar reduction treatments is driving carboxy therapy adoption. Technological advancements and aggressive marketing strategies are reinforcing Asia Pacific's leadership in aesthetic innovation.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by strong R&D and early technology adoption. The U.S. and Canada are embracing smart aesthetic devices with integrated analytics and cloud-based treatment tracking. Regulatory bodies are streamlining approval pathways for innovative non-invasive therapies, accelerating commercialization. Clinics are investing in training, certification, and bundled service offerings to enhance patient outcomes. The rise of wellness-focused consumers and demand for personalized skincare is boosting procedural volumes. As digital platforms and influencer ecosystems mature, North America continues to set the pace for aesthetic market evolution.

Key players in the market

Some of the key players profiled in the Carboxy Therapy Market include Fosun Pharmaceutical Co., Ltd., MBE Medical Division, Merz Pharma GmbH & Co. KGaA, Medipark Co., Ltd., Allergan plc, Italcarbo Srl, Alvi Prague, Mezopharma, JONTE, Kastner-Praxisbedarf, Anti-Aging Medical Systems, Carbossiterapia Italiana, DTA Medical, Beijing Jontelaser Technologies Co., Ltd., and Cosmo Pro Ltd.

Key Developments:

In July 2025, Neuco UnitedCo., Limited and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced the signing of an exclusive licensing agreement for the manufacturing and commercialization of AR1001 in Greater China, encompassing in Chinese mainland, Hong Kong Special Administrative Region (SAR), Macau SAR.

In April 2024, Merz Therapeutics has entered into an Asset Purchase Agreement to acquire two commercial medicines from NASDAQ-listed Acorda Therapeutics. Closing of the transaction would significantly contribute to the accelerated growth strategy of Merz Therapeutics.

Product Types Covered:

Tabletop Devices
Portable Devices
Other Product Types

Treatment Types Covered:

Medical Carboxytherapy
Cosmetic Carboxytherapy

Gas Types Covered:

Carbon Dioxide
Oxygen

Device Types Covered:

Stand-alone Devices
Handheld Devices

Applications Covered:

Stretch Marks
Cellulite Reduction
Alopecia
Pain Management
Psoriasis
Skin Rejuvenation
Dark Circles
Cardiovascular and Diabetic Applications
Regenerative Medicine
Other Applications

End Users Covered:

Hospitals
Aesthetic Clinics
Medspas
Spas and Salons
Beauty Centers
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Carboxy Therapy Market, By Product Type

5.1 Introduction
5.2 Tabletop Devices
5.3 Portable Devices
5.4 Other Product Types

6 Global Carboxy Therapy Market, By Treatment Type

6.1 Introduction
6.2 Medical Carboxytherapy
6.3 Cosmetic Carboxytherapy

7 Global Carboxy Therapy Market, By Gas Type

7.1 Introduction
7.2 Carbon Dioxide
7.3 Oxygen

8 Global Carboxy Therapy Market, By Device Type

8.1 Introduction
8.2 Stand-alone Devices
8.3 Handheld Devices

9 Global Carboxy Therapy Market, By Application

9.1 Introduction
9.2 Stretch Marks
9.3 Cellulite Reduction
9.4 Alopecia
9.5 Pain Management
9.6 Psoriasis
9.7 Skin Rejuvenation
9.8 Dark Circles
9.9 Cardiovascular and Diabetic Applications
9.10 Regenerative Medicine
9.11 Other Applications

10 Global Carboxy Therapy Market, By End User

10.1 Introduction
10.2 Hospitals
10.3 Aesthetic Clinics
10.4 Medspas
10.5 Spas and Salons
10.6 Beauty Centers
10.7 Other End Users

11 Global Carboxy Therapy Market, By Geography

11.1 Introduction
11.2 North America
- 11.2.1 US
- 11.2.2 Canada
- 11.2.3 Mexico
11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 Italy
- 11.3.4 France
- 11.3.5 Spain
- 11.3.6 Rest of Europe
11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 New Zealand
- 11.4.6 South Korea
- 11.4.7 Rest of Asia Pacific
11.5 South America
- 11.5.1 Argentina
- 11.5.2 Brazil
- 11.5.3 Chile
- 11.5.4 Rest of South America
11.6 Middle East & Africa
- 11.6.1 Saudi Arabia
- 11.6.2 UAE
- 11.6.3 Qatar
- 11.6.4 South Africa
- 11.6.5 Rest of Middle East & Africa

12 Key Developments

12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling

13.1 Fosun Pharmaceutical Co., Ltd.
13.2 MBE Medical Division
13.3 Merz Pharma GmbH & Co. KGaA
13.4 Medipark Co., Ltd.
13.5 Allergan plc
13.6 Italcarbo Srl
13.7 Alvi Prague
13.8 Mezopharma
13.9 JONTE
13.10 Kastner-Praxisbedarf
13.11 Anti-Aging Medical Systems
13.12 Carbossiterapia Italiana
13.13 DTA Medical
13.14 Beijing Jontelaser Technologies Co., Ltd.
13.15 Cosmo Pro Ltd

簡介目錄圖表

List of Tables

Table 1 Global Carboxy Therapy Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Carboxy Therapy Market Outlook, By Product Type (2024-2032) ($MN)
Table 3 Global Carboxy Therapy Market Outlook, By Tabletop Devices (2024-2032) ($MN)
Table 4 Global Carboxy Therapy Market Outlook, By Portable Devices (2024-2032) ($MN)
Table 5 Global Carboxy Therapy Market Outlook, By Other Product Types (2024-2032) ($MN)
Table 6 Global Carboxy Therapy Market Outlook, By Treatment Type (2024-2032) ($MN)
Table 7 Global Carboxy Therapy Market Outlook, By Medical Carboxytherapy (2024-2032) ($MN)
Table 8 Global Carboxy Therapy Market Outlook, By Cosmetic Carboxytherapy (2024-2032) ($MN)
Table 9 Global Carboxy Therapy Market Outlook, By Gas Type (2024-2032) ($MN)
Table 10 Global Carboxy Therapy Market Outlook, By Carbon Dioxide (2024-2032) ($MN)
Table 11 Global Carboxy Therapy Market Outlook, By Oxygen (2024-2032) ($MN)
Table 12 Global Carboxy Therapy Market Outlook, By Device Type (2024-2032) ($MN)
Table 13 Global Carboxy Therapy Market Outlook, By Stand-alone Devices (2024-2032) ($MN)
Table 14 Global Carboxy Therapy Market Outlook, By Handheld Devices (2024-2032) ($MN)
Table 15 Global Carboxy Therapy Market Outlook, By Application (2024-2032) ($MN)
Table 16 Global Carboxy Therapy Market Outlook, By Stretch Marks (2024-2032) ($MN)
Table 17 Global Carboxy Therapy Market Outlook, By Cellulite Reduction (2024-2032) ($MN)
Table 18 Global Carboxy Therapy Market Outlook, By Alopecia (2024-2032) ($MN)
Table 19 Global Carboxy Therapy Market Outlook, By Pain Management (2024-2032) ($MN)
Table 20 Global Carboxy Therapy Market Outlook, By Psoriasis (2024-2032) ($MN)
Table 21 Global Carboxy Therapy Market Outlook, By Skin Rejuvenation (2024-2032) ($MN)
Table 22 Global Carboxy Therapy Market Outlook, By Dark Circles (2024-2032) ($MN)
Table 23 Global Carboxy Therapy Market Outlook, By Cardiovascular and Diabetic Applications (2024-2032) ($MN)
Table 24 Global Carboxy Therapy Market Outlook, By Regenerative Medicine (2024-2032) ($MN)
Table 25 Global Carboxy Therapy Market Outlook, By Other Applications (2024-2032) ($MN)
Table 26 Global Carboxy Therapy Market Outlook, By End User (2024-2032) ($MN)
Table 27 Global Carboxy Therapy Market Outlook, By Hospitals (2024-2032) ($MN)
Table 28 Global Carboxy Therapy Market Outlook, By Aesthetic Clinics (2024-2032) ($MN)
Table 29 Global Carboxy Therapy Market Outlook, By Medspas (2024-2032) ($MN)
Table 30 Global Carboxy Therapy Market Outlook, By Spas and Salons (2024-2032) ($MN)
Table 31 Global Carboxy Therapy Market Outlook, By Beauty Centers (2024-2032) ($MN)
Table 32 Global Carboxy Therapy Market Outlook, By Other End Users (2024-2032) ($MN)